Professor's FDA-approved nanotechnology may prevent complications from implants - like the one that ended Kyrie Irving's season.
Following a procedure in March on Boston Celtics point guard Kyrie Irving's left knee, a bacterial infection was discovered, forcing him to have a follow-up procedure and miss the playoffs. Now, a newly FDA-approved orthopedic implant-with nanotechnology developed by professor Thomas Webster-could prevent similar infections. The first-of-its-kind device mimics the natural texture of bone, coaxing new bone growth and preventing bacteria from attaching to its surface.
